Cargando…
Liver transplantation in hepatocellular carcinoma – should we perform downstaging?
AIM: To compare the long-term outcomes between liver transplant (LT) recipients with hepatocellular carcinoma (HCC) who were downstaged with transarterial-chemoembolization (TACE) to the Milan criteria (MC) and those initially meeting the MC. METHODS: This retrospective study enrolled 198 patients w...
Autores principales: | Filipec Kanižaj, Tajana, Dinjar Kujundžić, Petra, Ostojić, Ana, Mijić, Maja, Sertić Milić, Helga, Mijić, Ana, Mateljak, Matija, Martinčević, Dora, Radetić, Eva, Vidjak, Vinko, Kocman, Branislav, Mikolašević, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468736/ https://www.ncbi.nlm.nih.gov/pubmed/36046928 http://dx.doi.org/10.3325/cmj.2022.63.317 |
Ejemplares similares
-
Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients
por: Mijic, Maja, et al.
Publicado: (2022) -
Liver transplantation in patients with neuroendocrine tumors: a case series and literature review
por: Ilić, Diana, et al.
Publicado: (2021) -
Inflammatory bowel disease in liver transplanted patients
por: Filipec Kanizaj, Tajana, et al.
Publicado: (2017) -
The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
por: Paklar, Natasa, et al.
Publicado: (2023) -
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2018)